Live Breaking News & Updates on Neurosense Therapeutics Company Profile Get Rating

Stay updated with breaking news from Neurosense therapeutics company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Sees Significant Increase in Short Interest

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 176,100 shares, an increase of 78.8% from the May 15th total of 98,500 shares. Based on an average daily volume of 3,790,000 shares, the short-interest ratio is […] ....

Neurosense Therapeutics Company Profile Get Rating , Citadel Advisors , Neurosense Therapeutics Ltd , Neurosense Therapeutics , Get Rating , Montreal Can , Street Group , Sense Therapeutics , Sense Therapeutics Company Profile , Sense Therapeutics Ltd , Nasdaq Nrsn ,

NeuroSense Therapeutics Ltd.'s (NASDAQ:NRSN) Lock-Up Period To End on June 7th

NeuroSense Therapeutics’ (NASDAQ:NRSN – Get Rating) lock-up period is set to end on Tuesday, June 7th. NeuroSense Therapeutics had issued 2,000,000 shares in its public offering on December 9th. The total size of the offering was $12,000,000 based on an initial share price of $6.00. After the end of the company’s lock-up period, restrictions preventing […] ....

Neurosense Therapeutics Company Profile Get Rating , Citadel Advisors , Neurosense Therapeutics Ltd , Neurosense Therapeutic , Get Rating , Sense Therapeutics , Neurosense Therapeutics , Street Group , Montreal Can , Sense Therapeutics Company Profile , Nasdaq Nrsn , Lock Up Expiration , Lock Up Period , Quiet Period ,

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Short Interest Update

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 98,500 shares, a growth of 64.2% from the April 30th total of 60,000 shares. Based on an average daily trading volume, of 4,200,000 shares, […] ....

Neurosense Therapeutics Company Profile Get Rating , Citadel Advisors , Neurosense Therapeutics Ltd , Neurosense Therapeutics , Get Rating , Sense Therapeutics , Montreal Can , Jane Street Group , Sense Therapeutics Company Profile , Nasdaq Nrsn ,

Head-To-Head Comparison: NeuroSense Therapeutics (NASDAQ:NRSN) and ImmunoGen (NASDAQ:IMGN)

ImmunoGen (NASDAQ:IMGN – Get Rating) and NeuroSense Therapeutics (NASDAQ:NRSN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings and […] ....

United States , United Kingdom , Amgen Oxford Biotherapeutics , Eli Lilly , Fusion Pharmaceuticals Inc , Macrogenics Inc , Debiopharm International , Cytomx Therapeutics Inc , Neurosense Therapeutics Ltd , Immunogen Company Profile Get Rating , Novartis Institutes For Biomedical Research Inc , Neurosense Therapeutics Company Profile Get Rating , Immunogen Inc , Get Rating , Neurosense Therapeutics , Given Neurosense Therapeutic , Neurosense Therapeutic , Sense Therapeutics , Gen Company Profile , Bayer Healthcare , Novartis Institutes , Biomedical Research , Cytomx Therapeutics , Sense Therapeutics Company Profile , Nasdaq Imgn , Stock Comparison ,